Contact this trialFirst, we need to learn more about you.
Androgen Receptor Inhibitor
Combination Therapy for Prostate Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is testing abiraterone acetate, prednisone, and apalutamide with or without ipilimumab or cabazitaxel and carboplatin to treat patients with castration-resistant prostate cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service